Iowa City, IA, United States of America

Joel V Weinstock

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2004-2015

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Joel V Weinstock

Introduction

Joel V Weinstock is a prominent inventor based in Iowa City, IA (US). He has made significant contributions to the field of medicine, particularly in the treatment of autoimmune diseases. With a total of 4 patents, his work focuses on utilizing parasitic biological agents for disease prevention and control.

Latest Patents

Weinstock's latest patents include innovative methods for treating excessive immune responses. One notable invention is the use of helminthic parasite preparations to reduce aberrant Th1 responses in individuals. This method is particularly directed towards treating autoimmune diseases such as Crohn's disease and ulcerative colitis, both classified as inflammatory bowel diseases (IBD). His inventions also extend to the treatment of other conditions, including rheumatoid arthritis, type 1 diabetes mellitus, lupus erythematosis, sarcoidosis, multiple sclerosis, autoimmune thyroiditis, allergic rhinitis, colon polyps, colon cancer, and asthma.

Career Highlights

Weinstock is affiliated with the University of Iowa Research Foundation, where he continues to advance his research and innovations. His work has garnered attention for its potential to revolutionize the treatment of various autoimmune conditions.

Collaborations

One of his notable collaborators is David E Elliott, with whom he has worked on various research projects related to his patents.

Conclusion

Joel V Weinstock's contributions to the field of medicine through his innovative patents highlight the potential of parasitic biological agents in treating autoimmune diseases. His ongoing research at the University of Iowa Research Foundation continues to pave the way for new therapeutic approaches.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…